Simplex Trading’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-43
| Closed | – | – | 9570 |
|
|
2025
Q2 | $0 | Buy |
+43
| New | +$184 | ﹤0.01% | 9240 |
|
|
2025
Q1 | – | Sell |
-400
| Closed | -$2.43K | – | 9109 |
|
|
2024
Q4 | $2K | Buy |
400
+21
| +6% | +$156 | ﹤0.01% | 8025 |
|
|
2024
Q3 | $2K | Hold |
379
| – | – | ﹤0.01% | 8026 |
|
|
2024
Q2 | $2K | Buy |
379
+286
| +308% | +$2.17K | ﹤0.01% | 8297 |
|
|
2024
Q1 | $0 | Sell |
93
-250
| -73% | -$2.28K | ﹤0.01% | 9376 |
|
|
2023
Q4 | $3K | Sell |
343
-1,054
| -75% | -$9.26K | ﹤0.01% | 8104 |
|
|
2023
Q3 | $16K | Buy |
1,397
+1,071
| +329% | +$19K | ﹤0.01% | 6820 |
|
|
2023
Q2 | $7K | Sell |
326
-419
| -56% | -$10.9K | ﹤0.01% | 7687 |
|
|
2023
Q1 | $23K | Buy |
+745
| New | +$43.1K | ﹤0.01% | 6781 |
|
|
2022
Q4 | – | Sell |
-970
| Closed | -$71.9K | – | 9833 |
|
|
2022
Q3 | $83K | Sell |
970
-1,659
| -63% | -$161K | ﹤0.01% | 5773 |
|
|
2022
Q2 | $217K | Buy |
2,629
+2,117
| +413% | +$187K | ﹤0.01% | 4503 |
|
|
2022
Q1 | $85K | Sell |
512
-1,039
| -67% | -$149K | ﹤0.01% | 6379 |
|
|
2021
Q4 | $259K | Buy |
+1,551
| New | +$175K | ﹤0.01% | 4792 |
|
|
2021
Q2 | – | Sell |
-41
| Closed | -$2.33K | – | 10388 |
|
|
2021
Q1 | $2K | Sell |
41
-37
| -47% | -$2.16K | ﹤0.01% | 8462 |
|
|
2020
Q4 | $4K | Buy |
78
+31
| +66% | +$1.72K | ﹤0.01% | 7791 |
|
|
2020
Q3 | $2K | Sell |
47
-46
| -49% | -$2.2K | ﹤0.01% | 7429 |
|
|
2020
Q2 | $4K | Buy |
+93
| New | +$4.69K | ﹤0.01% | 7055 |
|
Simplex Trading's KZR Position: Q3 2025 in Review
Simplex Trading sold out of Kezar Life Sciences (KZR) in Q3 2025, closing a stake of 43 shares.
Simplex Trading first reported a position in KZR in Q2 2020 and held it in 17 quarters. The position peaked at $259K in Q4 2021. 39 funds tracked by Wall St. Rank hold KZR as of Q3 2025.
- Simplex Trading reported no remaining Kezar Life Sciences position as of Q3 2025 after selling out during the quarter.
- Simplex Trading sold 43 Kezar Life Sciences shares in Q3 2025.
- Simplex Trading first reported a position in Kezar Life Sciences in Q2 2020 and held it in 17 quarters.
- Simplex Trading's Kezar Life Sciences position peaked at $259K in Q4 2021.
- 39 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q3 2025.
Based on Simplex Trading's 13F filing for Q3 2025, filed 12 Nov 2025.